COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 28th, 2003 • Nektar Therapeutics • Pharmaceutical preparations • California
Contract Type FiledMarch 28th, 2003 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of December 6, 2002, by and between INHALE THERAPEUTIC SYSTEMS, INC., a Delaware corporation with its principal office at 150 Industrial Road, San Carlos, California 94070 (the “Company”), and AFAC EQUITY L.P. a Delaware limited partnership with its offices c/o McKinsey & Company, Inc. United States at 55 East 52nd Street, 27th Floor, New York, New York 10022 (“AFAC” or, the “Purchaser”).
Dr. Arnold J. Repta Park City, UT 84098 Re: Letter Agreement covering Change in Control Dear Arnie,Nektar Therapeutics • March 28th, 2003 • Pharmaceutical preparations
Company FiledMarch 28th, 2003 IndustryThis will formalize our understanding in the event of an entity “Change in Control,” defined as the circumstances whereby any third part entity acquires 50% or more of the Common Stock in Inhale Therapeutic Systems, Inc.,